APA (7th ed.) Citation

Rosar, F., Schuler, J., Burgard, C., Blickle, A., Bartholomä, M., Maus, S., . . . Ezziddin, S. (2024). Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC. European Journal of Nuclear Medicine and Molecular Imaging, 51(13), 4151-4162. https://doi.org/10.1007/s00259-024-06825-4

Chicago Style (17th ed.) Citation

Rosar, Florian, et al. "Efficacy and Safety of Rechallenge [177Lu]Lu-PSMA-617 RLT After Initial Partial Remission in Patients with MCRPC." European Journal of Nuclear Medicine and Molecular Imaging 51, no. 13 (2024): 4151-4162. https://doi.org/10.1007/s00259-024-06825-4.

MLA (9th ed.) Citation

Rosar, Florian, et al. "Efficacy and Safety of Rechallenge [177Lu]Lu-PSMA-617 RLT After Initial Partial Remission in Patients with MCRPC." European Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 13, 2024, pp. 4151-4162, https://doi.org/10.1007/s00259-024-06825-4.